UVA-induced apoptosis studied by the new apo/necro-Comet-assay which distinguishes viable, apoptotic and necrotic cells.
An adaptation of the Comet-assay was developed which enables the discrimination of viable, apoptotic and necrotic single cells by use of the common Annexin-V staining and a dye exclusion test on the cells already embedded in agarose gel on glass slides. Membrane integrity (Ethidium-Homodimer exclusion), cellular esterase activity (Calcein blue-AM) as well as translocation of phosphadidyl-serine (Annexin-V) were analysed using these stains. The advantage of the 'apo/necro-Comet-assay' is that the viability status of individual cells can be determined and correlated with the DNA fragmentation pattern (comet) formed by the same cells. Hence, DNA damage can be assessed and correlated with viable cells or cells undergoing early, mid- or late stage apoptosis or necrosis as identified by the staining pattern. The staining was verified using heat and etoposide-induced apoptosis. This technique, among others, was used to study whether apoptotic fragmentation interferes with repair kinetics measured with the comet assay following UVA exposure (doses up to 1,280 kJ/m(2)) in the cultured human keratinocytes (HaCaT). Therefore, a time course of apoptotic events (phosphatidyl translocation and TUNEL fragmentation) was established and correlated to the DNA fragmentation in the comet-assay. Apoptotic cells were detected more than 8 h later. The combined three-colour staining method with the comet assay showed that there was no significant interference of DNA repair by apoptotic fragmentation processes since DNA repair was almost completed before the onset of apoptotic fragmentation. The apo/necro-Comet-assay reduces the general problem of false-positive results in genotoxicity tests using the Comet-assay.
Morley
N
N
Royal Cornwall Hospital NHS Trust, Sunrise Centre, Royal Cornwall Hospital, Treliske, Truro, UK. nick.morley@rcht.cornwall.nhs.uk
Rapp
A
A
Dittmar
H
H
Salter
L
L
Gould
D
D
Greulich
K O
KO
Curnow
A
A
D017304:Annexin A5 / Q000494:pharmacology; D017209:Apoptosis; D002478:Cells, Cultured; D020552:Comet Assay / Q000379:methods*; D053938:DNA Fragmentation; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D020287:In Situ Nick-End Labeling; D007700:Kinetics; D009336:Necrosis; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D010575:Pesticides; D013997:Time Factors; D014343:Trypan Blue / Q000494:pharmacology; D014466:Ultraviolet Rays
D017304:Annexin A5; D019384:Nucleic Acid Synthesis Inhibitors; D010575:Pesticides; D005047:Etoposide; D014343:Trypan Blue